Green Cross Health Limited (GXH.NZ)
- Previous Close
0.7200 - Open
0.7200 - Bid 0.7100 x 200000
- Ask 0.7200 x 436000
- Day's Range
0.7200 - 0.7200 - 52 Week Range
0.7100 - 1.0300 - Volume
19,965 - Avg. Volume
16,158 - Market Cap (intraday)
103.557M - Beta (5Y Monthly) 0.00
- PE Ratio (TTM)
9.00 - EPS (TTM)
0.0800 - Earnings Date May 28, 2025 - Jun 3, 2025
- Forward Dividend & Yield 0.05 (6.25%)
- Ex-Dividend Date Dec 4, 2024
- 1y Target Est
--
Green Cross Health Limited provides health care and advice services to communities in New Zealand. It operates through Pharmacy Services and Medical Services segments. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores. It operates approximately 345 community pharmacies under the Unichem and Life Pharmacy brands. The Medical Services segment operates owned and equity accounted medical centres; and offers support services provided to its medical centres, as well as medical centres outside the company. It also provides back office and operational services to medical centres; and offers family healthcare services through GP, accident, and medical centres under The Doctors brand. Green Cross Health Limited was incorporated in 1999 and is based in Auckland, New Zealand.
www.greencrosshealth.co.nz--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: GXH.NZ
View More
Performance Overview: GXH.NZ
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GXH.NZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GXH.NZ
View MoreValuation Measures
Market Cap
103.39M
Enterprise Value
217.47M
Trailing P/E
8.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.20
Price/Book (mrq)
0.66
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
4.73
Financial Highlights
Profitability and Income Statement
Profit Margin
2.30%
Return on Assets (ttm)
5.28%
Return on Equity (ttm)
9.79%
Revenue (ttm)
513.61M
Net Income Avi to Common (ttm)
12.07M
Diluted EPS (ttm)
0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
28.85M
Total Debt/Equity (mrq)
84.41%
Levered Free Cash Flow (ttm)
31.64M